
Sign up to save your podcasts
Or
This week James is joined by Dr Mark Kotter, a stem cell biologist and neurosurgeon at the University of Cambridge. He is the founder and CEO of bit.bio, who have developed opti-ox, a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He also founded cultured meat startup Meatable.
Subscribe to Healthtech Pigeon đŠ: www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk
4.6
55 ratings
This week James is joined by Dr Mark Kotter, a stem cell biologist and neurosurgeon at the University of Cambridge. He is the founder and CEO of bit.bio, who have developed opti-ox, a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He also founded cultured meat startup Meatable.
Subscribe to Healthtech Pigeon đŠ: www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk
36 Listeners
1,043 Listeners
523 Listeners
1,937 Listeners
7,037 Listeners
3,761 Listeners
13 Listeners
197 Listeners
610 Listeners
144 Listeners
6 Listeners
156 Listeners
2,035 Listeners
0 Listeners
191 Listeners